• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR OMNILINK ELITE PERIPHERAL STENT SYSTEM; PERIPHERAL STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR OMNILINK ELITE PERIPHERAL STENT SYSTEM; PERIPHERAL STENT DELIVERY SYSTEM Back to Search Results
Catalog Number UNK OMNILINK ELITE
Device Problems Off-Label Use (1494); Migration (4003)
Patient Problem Aneurysm (1708)
Event Date 05/01/2021
Event Type  Injury  
Manufacturer Narrative
B3: date of event ¿ estimated.D4: the unique device identifier (udi) is unknown because the part number and lot number were not provided.D6a: date of implant ¿ estimated.H6- device code 1494 clarifier: incorrect anatomy.Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.Literature attachment: title - percutaneous duplication of the thoracic aorta in a child: part 2.The other omnilink elitestent referenced in b5 is filed under separate medwatch report number.
 
Event Description
It was reported through a research article, identifying the omnilink stent that may be related to: stent migration, stenosis and additional intervention.The patient, with a history of history of severe aortic coarctation, underwent surgical implantation of a non-abbott bypass shunt at the age of 2.At the age of 9, the patient underwent magnetic resonance imaging which showed complete occlusion of the native aorta and stenosis of the bypass at its proximal insertion.Two 10 mm omnilink stents were implanted, overlapping, to achieve recanalization of the native aorta.An additional 10mm omnilink stent was implanted at the proximal portion of the bypass.The article noted that the patient height was 130 cm and weight was 29 kg at the time of the procedure.Three years post procedure, the patient underwent computed tomography which showed proximal migration of the upper omnilink stent and loss of the overlap between the two omnilink stents (previously overlapping) in the native aorta.Additionally, a large aneurysm was present.The article noted that, at this time, the patient height was 155 cm and weight was 42 kg.The patient underwent cardiac catheterization and a single non-abbott covered stent was implanted to exclude the aneurysm.The proximal stented portion of the bypass was dilated using a non-abbott dilatation catheter balloon.The conclusion of the article was that some interventions on children's growing structures should not be consider as definitive and require careful follow up to detect possible complications requiring treatment.Details are listed in the attached article, titled percutaneous duplication of the thoracic aorta in a child: part 2.Please see article for additional information.
 
Manufacturer Narrative
The device was not returned for evaluation.A review of the lot history record and complaint history of the reported device could not be conducted because the part and lot numbers were not provided.It was reported that two 10 mm omnilink stents were implanted, overlapping, to achieve recanalization of the native aorta.An additional 10mm omnilink stent was implanted at the proximal portion of the bypass.It should be noted that the omnilink elite instructions for use (ifu), states: the omnilink elite stent system is indicated for the treatment of atherosclerotic iliac artery lesions.It is possible that the ifu deviation caused/contributed to the reported event.The investigation was unable to determine a conclusive cause for the reported stent migration.The reported patient effect of aneurysm is listed in the omnilink elite ifu as a known patient effect of coronary stenting procedures.A conclusive cause for the reported patient effect of aneurysm, and the relationship to the product, if any, cannot be determined.The subsequent unexpected medical intervention (additional therapy/non-surgical treatment) appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OMNILINK ELITE PERIPHERAL STENT SYSTEM
Type of Device
PERIPHERAL STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key17065662
MDR Text Key316573425
Report Number2024168-2023-05914
Device Sequence Number1
Product Code NIO
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P110043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/20/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK OMNILINK ELITE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/15/2023
Initial Date FDA Received06/05/2023
Supplement Dates Manufacturer Received06/27/2023
Supplement Dates FDA Received07/20/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age9 YR
Patient Weight29 KG
-
-